Rabisin
Rabisin
Authorised
- Rabies virus, strain G52, Inactivated
Product identification
Medicine name:
Rabisin
Active substance:
- Rabies virus, strain G52, Inactivated
Target species:
-
Cattle
-
Sheep
-
Horse
-
Other Mammals
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabies virus, strain G52, Inactivated0.00/milligram(s)1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Cattle
- Sheep
-
Meat and offal0day
-
- Horse
- Other Mammals
-
Subcutaneous use
- Cattle
- Dog
- Cat
- Other Mammals
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Type I glass vials with butyl-elastomer closure. Package sizes: Bottle (glass) of 1 dose of suspension, box of 1 bottle
- Type I glass vials with butyl-elastomer closure. Package sizes: Bottle (glass) of 1 dose of suspension, box of 10 bottles
- Type I glass vials with butyl-elastomer closure. Package sizes: Bottle (glass) of 1 dose of suspension, box of 100 bottles
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10454/074/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 8/03/2023
How useful was this page?:
